Figure 1. Psoriatic and HS lesions of patient 1.
( a– e) Psoriatic and HS lesions of first patient before treatment with certolizumab pegol. ( f– j) Psoriatic and HS lesions of first patient after treatment with certolizumab pegol.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.